Marks & Spencer Group plc buy krebskrebs
Start price
29.06.20
/
50%
€1.13
Target price
04.11.21
€1.40
Performance (%)
99.82%
End price
05.11.21
€2.26
Summary
This prediction ended on 05.11.21 with a price of €2.26. The BUY prediction by krebskrebs for Marks & Spencer Group plc saw massive gains of 99.82%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marks & Spencer Group plc | -5.547% | -5.547% | -24.336% | 157.527% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by krebskrebs for this prediction
In the thread Marks & Spencer Group plc diskutieren
Buy mit Kursziel 1,4
In the thread Trading Marks & Spencer Group plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

